Mingming Qi
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
-
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Tryptophan and brain disorders 2
- Oncology 4
- Co-authors
- Weiwei Tao (2 shared papers)Yuxin Dai (1 shared paper)Yue Hu (1 shared paper)Weiguo Dong (4 shared papers)Min Zhao (2 shared papers)Guangda Yao (2 shared papers)Mingyuan Wang (3 shared papers)Tong Tao Zhao (2 shared papers)
In The Last Decade
Mingming Qi
16 papers receiving 380 citations
Peers
Comparison fields: 5 of 60
- Biological Psychiatry 36
- Neurology 46
- Developmental Neuroscience 17
- Complementary and alternative medicine 46
- Pharmacology 51
Countries citing papers authored by Mingming Qi
This map shows the geographic impact of Mingming Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingming Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingming Qi more than expected).
Fields of papers citing papers by Mingming Qi
This network shows the impact of papers produced by Mingming Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingming Qi. The network helps show where Mingming Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingming Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 112 | |
| 2 | 2022 | 66 | |
| 3 | 2021 | 36 | |
| 4 | 2006 | 35 | |
| 5 | 2020 | 26 | |
| 6 | 2022 | 23 | |
| 7 | 2023 | 23 | |
| 8 | 2022 | 16 | |
| 9 | 2020 | 14 | |
| 10 | 2022 | 11 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 3 | |
| 14 | 2025 | 3 | |
| 15 | 2025 | 2 | |
| 16 | [Protective effect of bombesin receptor subtype-3 on human brochial epithelial cells against injury]. | 2006 | 1 |
About Mingming Qi
Mingming Qi is a scholar working on Biological Psychiatry, Oncology, Rehabilitation, Molecular Medicine and Neurology, having authored 16 papers that have together received 388 indexed citations. Recurring topics across this work include Magnolia and Illicium research (2 papers), Curcumin's Biomedical Applications (2 papers), Neuropeptides and Animal Physiology (2 papers), Tryptophan and brain disorders (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Pancreatitis Pathology and Treatment (2 papers), Cervical Cancer and HPV Research (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Biological Psychiatry (36 citations), Neurology (46 citations), Developmental Neuroscience (17 citations), Complementary and alternative medicine (46 citations) and Pharmacology (51 citations). Mingming Qi has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Weiwei Tao, Yuxin Dai, Yue Hu, Weiguo Dong, Min Zhao, Guangda Yao, Mingyuan Wang, Tong Tao Zhao, Pengzhan He and Yinghui Liu. Their work appears in journals such as Frontiers in Pharmacology, Journal of Ovarian Research, Cancer Gene Therapy, Frontiers in Cell and Developmental Biology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.